Source: Ohio Board of Pharmacy
On May 15, In response to the increasing number of retail IV therapy clinics operating in the state, the State Medical Board of Ohio (SMBO), the Ohio Board of Pharmacy (OBP), and the Ohio Board of Nursing (OBN) (collectively the “Boards”) issued a joint regulatory statement highlighting critical patient safety concerns and the importance of regulatory compliance in this emerging sector.
“As medical regulators, the responsibility of ensuring safe boundaries with emerging trends falls to us,” said SMBO Executive Director Stephanie Loucka. “The SMBO is committed to enforcing its laws and rules to ensure that Ohio patients are treated by appropriately licensed and trained medical professionals, in any setting.”
Retail IV therapy clinics have proliferated across Ohio, often offering the administration of preselected IV fluid “cocktails” that include a mix of saline, vitamins, prescription drugs, and amino acids. While these services claim to treat conditions such as dehydration, migraines, and to enhance athletic recovery, the Boards emphasize that such IV therapy is a medical practice requiring licensed professionals and compliance with Ohio laws and regulations.
“The OBP has rules in place to ensure the safe preparation of IVs and other drug therapies administered by these clinics,” said OBP Executive Director Steven W. Schierholt. “Failure to comply with these standards can have serious adverse impacts on patient health.”
The joint regulatory statement includes important reminders about the use of qualified staff to diagnose and treat patients, adhering to the scope of practice for healthcare professionals established by law, compliance with Ohioʼs drug compounding rules, appropriate use of drug administration protocols, ensuring proper clinic oversight, and other concerns observed by the Boards.
“Nurses engaging in practice in IV therapy clinics or elsewhere are obligated to act deliberately and responsibly, by fully understanding and complying with Ohio law and rules summarized in the joint regulatory statement, to ensure the safety and protection of the patients in their care,” said OBN Executive Director Marlene Anielski.
The Boards urge all licensed professionals to review their legal responsibilities and confirm compliance with state laws and rules as outlined in the joint regulatory statement. As the practice of retail IV therapy continues to evolve, it is imperative that Ohio healthcare professionals uphold the highest standards of practice to safeguard patient health and safety.